FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: biotechnology

Sort
E.g., 2013-05-20
E.g., 2013-05-20
Enter a comma separated list of user names.

Jim Boeheim and Cellceutix (CTIX) Team to Fight Cancer
Posted by OTC Showcase on May 7th, 2012

Clinical trials should be starting at Harvard's Dana-Farber Cancer Center in the next two months as Cellceutix looks to validate their laboratory research on Kevetrin, their novel drug in development for the treatment of drug resistant cancers. Yesterday, it was disclosed that Syracuse basketball icon Jim Boeheim has come on board the Cellceutix team in the fight against cancer.

Read More
comment 0
Share
Tags:
biotechnology, Biotechnology Stocks, Cellceutix, CTIX, Kevetrin, new cancer drugs, Jim Boeheim

(GCA, DSCO, ADGF) PennyOmega.com Watch List for Wed Mar. 07, 2012
Posted by pennylynnomega on March 6th, 2012

chartstockalert

Read More
comment 0
Share
Tags:
biotechnology, golfers, DSCO, NYSE:GCA, GCA, NASDAQ:DSCO, NASDAQ:ADGF, ADGF, golf products, Discovery Laboratories, Adams Golf, Global Cash Access, SURFAXIN, Respiratory Distress Syndrome, pulmonary surfactant

Cellceutix Featured on Front Page of Boston Business Journal
Posted by OTC Showcase on January 23rd, 2012

Cellceutix continues to gain industry attention by both investors, big pharma and publications. Their Chief Executive Officer was featured on the front page of Friday's Boston Business Journal. As the clinical trials for Kevetrin should be starting in a couple months at Dana-Farber, attention should continue to increase.

Read More
comment 0
Share
Tags:
biotechnology, cancer, Biotech Stocks, Cellceutix, CTIX, new cancer drugs, Boston Business Journal

SDIX, CRWE, SBGI, XATA, SEAC Stock Market Report from PennyOtcStock
Posted by Steve Stock on December 12th, 2011

SDIX? (NASDAQ: SDIX), recently announced that it has successfully completed its previously announced sale of the assets of its water quality division to Modern Water plc for $4.5 million. Modern Water acquired the division's intellectual property, current inventory and commercial contracts, as well as its equipment and staff.

Read More
comment 0
Share
Tags:
biotechnology, Crown Equity Holdings, SeaChange International, NASDAQ:SEAC, NASDAQ:XATA, XATA, Nasdaq:SBGI, Sinclair Broadcast, NASDAQ:SDIX, electronic media services, Modern Water plc, SDIX, crwetube.com

Why Athersys (ATHX) Is A Compelling Investment Opportunity
Posted by ghawman1 on September 8th, 2011

Athersys Inc. (NASDAQ: ATHX) is a company focused on regenerative medicine, similar to companies like Osiris Therapeutics Inc. (NASDAQ: OSIR), Mesoblast (ASX:MSB), and Cytori (NASDQ: CYTX) and others that are developing a stem cell platform to target a range of disease indications.

Read More
comment 0
Share
Tags:
biotech, biotechnology, investing in biotech, Biotech Stocks, regenerative medicine, ATHX

Identifying Compelling Investment Opportunities In The Biotechnology Sector

Posted by ghawman1 on September 6th, 2011

How does an investor measure the potential value of a new therapy or technology? From a financial perspective, the classical approach is to consider the following questions:

v How large is the potential market for a given product, in terms of number of potential patients, and potential dollar value?

Read More
comment 0
Share
Tags:
investment ideas, biotech, biotechnology, investing in biotech, Biotech Stocks, stroke, ATHX, Athersys

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at Three September Healthcare Conferences
Posted by investid on September 1st, 2011

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that BioSante will present at three healthcare conferences in September.

Read More
comment 0
Share
Tags:
finance, Stocks, Investing, markets, Healthcare, biotechnology, pharmaceutical, BPAX, BioSante

Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Announces Cancer Studies
Posted by investid on August 24th, 2011

Biotech/Medical Technology Stock News; Aethlon Medical (OTCBB: AEMD) Announces Sarcoma, Lung Cancer, Prostate Cancer, Metastatic Melanoma, and Head and Neck Cancer Studies

Read More
comment 0
Share
Tags:
finance, Stocks, Investing, markets, biotechnology, medical devices, AEMD, Aethlon

Athersys (ATHX) Reports Rapid Clinical Progress Second Quarter
Posted by ghawman1 on August 17th, 2011

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life.

Read More
comment 0
Share
Tags:
biotech, biotechnology, stem cells, regenerative medicine, ATHX, Athersys, Progress

Cardium (CXM) Reports On Near-Term Milestones
Posted by ghawman1 on August 17th, 2011

Cardium Therapeutics (NYSE AMEX: CXM) specializes in the acquisition and commercialization of strategically misaligned or undervalued medical assets from large pharmaceutical companies, venture capital funds or institutional investors.

Read More
comment 0
Share
Tags:
biotech, invest, biotechnology, diversified, Cardium, milestones

Pages

ADVERTISE WITH US